Aurinia Pharmaceuticals
AUPH
AUPH
184 hedge funds and large institutions have $548M invested in Aurinia Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 68 increasing their positions, 45 reducing their positions, and 30 closing their positions.
Holders
184
Holders Change
-6
Holders Change %
-3.16%
% of All Funds
2.95%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
27
Increased
68
Reduced
45
Closed
30
Calls
$30.4M
Puts
$21.7M
Net Calls
+$8.65M
Net Calls Change
+$2.62M
Top Buyers
1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$14.4M |
2 |
2
Goldman Sachs
New York
|
$10.8M |
3 |
3
D.E. Shaw & Co
New York
|
$5.54M |
4 |
4
Morgan Stanley
New York
|
$20.5M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$11.6M |